Skip to main content Accessibility help
×
Home
Hostname: page-component-544b6db54f-zts5g Total loading time: 0.245 Render date: 2021-10-20T06:27:14.356Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Plasma and CSF Gaba in Affective Illness

Published online by Cambridge University Press:  29 January 2018

Wade H. Berrettini*
Affiliation:
Bldg. 10, Rm. 3N218, NIMH, 9000 Rockvilie Pike, Bethesda, Maryland 20205, USA
John I. Nurnberger Jr.
Affiliation:
Section on Psychogenetics, Biological Psychiatry Branch, NIMH
Theodore Hare
Affiliation:
Department of Pharmacology, Thomas Jefferson University, Philadelphia, Pennyslvania 19107
Elliott S. Gershon
Affiliation:
Biological Psychiatry Branch, NIMH
Robert M. Post
Affiliation:
Section on Psychobiology, Biological Psychiatry Branch, NIMH
*
Correspondence.

Summary

CSF and plasma GABA was measured in patients with bipolar affective illness and matched controls. There was no correlation between CSF and plasma GABA in 10 pairs of simultaneously obtained samples. Plasma GABA was significantly lower in a group of 10 euthymic medication-free bipolar patients compared to 41 normal volunteers (P <.02). This finding was replicated in a second study involving 6 patients and 10 normal volunteers. Twin studies showed a high correlation between members of 11 monozygotic twin pairs (P <.008). Diurnal variation was minimal, but bimonthly sampling over one year revealed somewhat higher values in the late summer compared to late winter.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Balletto, E., Cherchi, M. A., Arillo, A., Doria-Lamba, L., Melodia, F. & Mensi, P. (1978) GABA synthesis in erythrocytes of Testudo hermanni Gmelin. Communications in Biochemistry and Physiology, 61, 281–2.Google ScholarPubMed
Bernasconi, R. & Martin, P. (1979) Effects of antiepileptic drugs on the GABA turnover rate. Archives of Pharmacology, 307, 251.Google Scholar
Berrettini, W. H. & Post, R. M. (1982) GABA in affective illness. In Neurobiology of Mood Disorders (ed. Post, R. M. and Ballenger, J.). Baltimore: Williams & Wilkins (in press).Google ScholarPubMed
Emrich, H. M., v. Zerssen, O., Kissling, W., Moller, H. J. & Windorfer, A. (1980) Effect of sodium valproate on mania. Archives Psychiatrica Nervenkranken, 229, 121.CrossRefGoogle ScholarPubMed
Ferkany, J. W., Butler, I. J. & Enna, S. J. (1979) Effect of drugs on rat brain CSF and blood GABA content. Journal of Neurochemistry, 33, 2933.CrossRefGoogle Scholar
Ferkany, J. W., Smith, L. A., Seifert, W. E. Jr., Caprioli, R. M. & Enna, S. J. (1978) Measurement of GABA in blood. Life Sciences, 22, 2121–8.Google ScholarPubMed
Gerner, R. H. & Hare, T. A. (1981) CSF GABA in normals, depression, schizophrenia, mania and anorexia nervosa. American Journal of Psychiatry, 138, 1098–101.Google Scholar
Glaesar, B. S. & Hare, T. A. (1975) Measurement of GABA in human cerebrospinal fluid. Biochemical Medicine, 12, 274–82.Google Scholar
Gold, B. I., Bowers, M. B. Jr., Roth, R. H. & Sweeney, D. W. (1980) GABA levels in CSF of patients with psychiatric disorders. American Journal of Psychiatry, 137, 362–4.Google ScholarPubMed
Green, A. R., Peralta, E., Hong, J. S., Mao, C. C., Atterwill, C. K. & Costa, E. (1978) Alterations in GABA metabolism and met-enkephalin content in rat brain following repeated electroconvulsive shocks. Journal of Neurochemistry, 31, 607–18.CrossRefGoogle ScholarPubMed
Grossman, N. H., Hare, T. A., Manyam, M. V. B., Glaesar, B. S. & Wood, J. H. (1980) Stability of GABA levels in CSF under various conditions of storage. Brain Research, 182, 99.CrossRefGoogle ScholarPubMed
Hare, T. A. & Manyam, N. V. B. (1980) Rapid and sensitive ion-exchange fluorometric measurement of GABA in physiologic fluids. Analytical Biochemistry, 101, 349–55.CrossRefGoogle Scholar
Kuriyama, K. & Sze, P. Y. (1970) Penetration of GABA across the blood-brain barrier. Pharmacologist, 13, 207–12.Google Scholar
Loscher, W. (1979) GABA in plasma and CSF of different species. Effects of γ-acetylenic GABA, γ-vinyl GABA and sodium valproate. Journal of Neurochemistry, 32, 1587–91.CrossRefGoogle Scholar
Loscher, W. & Schmidt, D. (1981) Plasma GABA levels in neurological patients under treatment with valproic acid. Life Sciences, 28, 2383–8.CrossRefGoogle ScholarPubMed
Maggi, A. & Enna, S. J. (1980) Regional alterations in rat brain neurotransmitter systems following chronic lithium treatment. Journal of Neurochemistry, 34, 888–92.CrossRefGoogle ScholarPubMed
Manyam, N. V. B., Hare, T. A. & Katz, Z. (1980) Effect of isoniazid on CSF and plasma GABA levels in Huntington's Disease. Life Sciences, 26, 1303–8.CrossRefGoogle Scholar
Mazure, C. & Gershon, E. S. (1979) Blindness and reliability in lifetime psychiatric diagnosis. Archives of General Psychiatry, 127, 110.Google Scholar
Morselli, P. L., Bossi, L., Henry, J. F., Zarifian, E. & Bartholini, G. (1980) On the therapeutic action of SL 76 002, a new GABA-mimetic agent. Brain Research Bulletin, 5 (Supplement), 411–15.CrossRefGoogle Scholar
Nakamura, S., Miyata, S. & Kameyama, M. (1978) Serum DBH, GAD and serum amino acid decarboxylase in involuntary movement disorders. Rinsho Shinkeigaku, 19, 511–14.Google Scholar
Petty, F. & Schlesser, M. A. (1981) Plasma GABA in affective illness. Journal of Affective Disorders, 3, 334–43.CrossRefGoogle ScholarPubMed
Sherman, A. D. & Petty, F. (1980) Neurochemical basis of the action of antidepressants on learned helplessness. Behavioral and Neural Biology, 30, 119–34.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.
50
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Plasma and CSF Gaba in Affective Illness
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Plasma and CSF Gaba in Affective Illness
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Plasma and CSF Gaba in Affective Illness
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *